100 related articles for article (PubMed ID: 7577470)
41. Evidence for two bladder cancer suppressor loci on human chromosome 9.
Ruppert JM; Tokino K; Sidransky D
Cancer Res; 1993 Nov; 53(21):5093-5. PubMed ID: 8221642
[TBL] [Abstract][Full Text] [Related]
42. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder.
Keen AJ; Knowles MA
Oncogene; 1994 Jul; 9(7):2083-8. PubMed ID: 8208555
[TBL] [Abstract][Full Text] [Related]
43. A cell cycle regulator potentially involved in genesis of many tumor types.
Kamb A; Gruis NA; Weaver-Feldhaus J; Liu Q; Harshman K; Tavtigian SV; Stockert E; Day RS; Johnson BE; Skolnick MH
Science; 1994 Apr; 264(5157):436-40. PubMed ID: 8153634
[TBL] [Abstract][Full Text] [Related]
44. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.
Nobori T; Miura K; Wu DJ; Lois A; Takabayashi K; Carson DA
Nature; 1994 Apr; 368(6473):753-6. PubMed ID: 8152487
[TBL] [Abstract][Full Text] [Related]
45. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction.
Cairns P; Tokino K; Eby Y; Sidransky D
Cancer Res; 1994 Mar; 54(6):1422-4. PubMed ID: 8137242
[TBL] [Abstract][Full Text] [Related]
46. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.
Noda A; Ning Y; Venable SF; Pereira-Smith OM; Smith JR
Exp Cell Res; 1994 Mar; 211(1):90-8. PubMed ID: 8125163
[TBL] [Abstract][Full Text] [Related]
47. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.
Xiong Y; Zhang H; Beach D
Genes Dev; 1993 Aug; 7(8):1572-83. PubMed ID: 8101826
[TBL] [Abstract][Full Text] [Related]
48. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
Cairns P; Shaw ME; Knowles MA
Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
[TBL] [Abstract][Full Text] [Related]
49. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.
Hannon GJ; Beach D
Nature; 1994 Sep; 371(6494):257-61. PubMed ID: 8078588
[TBL] [Abstract][Full Text] [Related]
50. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
Toyoshima H; Hunter T
Cell; 1994 Jul; 78(1):67-74. PubMed ID: 8033213
[TBL] [Abstract][Full Text] [Related]
51. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
Polyak K; Lee MH; Erdjument-Bromage H; Koff A; Roberts JM; Tempst P; Massagué J
Cell; 1994 Jul; 78(1):59-66. PubMed ID: 8033212
[TBL] [Abstract][Full Text] [Related]
52. p16 gene in uncultured tumours.
Spruck CH; Gonzalez-Zulueta M; Shibata A; Simoneau AR; Lin MF; Gonzales F; Tsai YC; Jones PA
Nature; 1994 Jul; 370(6486):183-4. PubMed ID: 8028660
[No Abstract] [Full Text] [Related]
53. Tumor-suppressor genes. Open questions on p16.
Bonetta L
Nature; 1994 Jul; 370(6486):180. PubMed ID: 8028659
[No Abstract] [Full Text] [Related]
54. Rates of p16 (MTS1) mutations in primary tumors with 9p loss.
Cairns P; Mao L; Merlo A; Lee DJ; Schwab D; Eby Y; Tokino K; van der Riet P; Blaugrund JE; Sidransky D
Science; 1994 Jul; 265(5170):415-7. PubMed ID: 8023167
[No Abstract] [Full Text] [Related]
55. A challenge to p16 gene as a major tumor suppressor.
Marx J
Science; 1994 Jun; 264(5167):1846. PubMed ID: 8009205
[No Abstract] [Full Text] [Related]
56. Cell cycle control and cancer.
Hartwell LH; Kastan MB
Science; 1994 Dec; 266(5192):1821-8. PubMed ID: 7997877
[TBL] [Abstract][Full Text] [Related]
57. Deletion of p16 and p15 genes in brain tumors.
Jen J; Harper JW; Bigner SH; Bigner DD; Papadopoulos N; Markowitz S; Willson JK; Kinzler KW; Vogelstein B
Cancer Res; 1994 Dec; 54(24):6353-8. PubMed ID: 7987828
[TBL] [Abstract][Full Text] [Related]
58. Germline p16 mutations in familial melanoma.
Hussussian CJ; Struewing JP; Goldstein AM; Higgins PA; Ally DS; Sheahan MD; Clark WH; Tucker MA; Dracopoli NC
Nat Genet; 1994 Sep; 8(1):15-21. PubMed ID: 7987387
[TBL] [Abstract][Full Text] [Related]
59. Normal human urothelial cells in vitro: proliferation and induction of stratification.
Southgate J; Hutton KA; Thomas DF; Trejdosiewicz LK
Lab Invest; 1994 Oct; 71(4):583-94. PubMed ID: 7967513
[TBL] [Abstract][Full Text] [Related]
60. Genetics of Wilms' tumor: a blend of aberrant development and genomic imprinting.
Junien C; Henry I
Kidney Int; 1994 Nov; 46(5):1264-79. PubMed ID: 7853785
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
